Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon

Core Points - Broadwood Partners, L.P. and its affiliates have commented on STAAR Surgical Company's recent filing with the SEC regarding a supplement to its definitive proxy statement related to the proposed acquisition by Alcon Inc. [1] Company Summary - Broadwood Partners owns 27.5% of STAAR Surgical Company [1]